Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2323
Source ID: NCT00329225
Associated Drug: Rosiglitazone
Title: Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: rosiglitazone
Outcome Measures: Primary: HbA1c at each visit, 28 Weeks | Secondary: FPG at each visit C-peptide at each visit lipids at each visit BNP at each visit CRP at each visit PAI-1 at each visit MMP-9 at each visit, 28 Weeks
Sponsor/Collaborators: Sponsor: GlaxoSmithKline
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 630
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2002-09
Completion Date: 2004-04
Results First Posted:
Last Update Posted: 2016-09-15
Locations: GSK Investigational Site, Birmingham, Alabama, 35205, United States|GSK Investigational Site, Birmingham, Alabama, 35234, United States|GSK Investigational Site, Fairfield, Alabama, 35064, United States|GSK Investigational Site, Fultondale, Alabama, 35068, United States|GSK Investigational Site, Montgomery, Alabama, 36106, United States|GSK Investigational Site, Phoenix, Arizona, 85016, United States|GSK Investigational Site, Phoenix, Arizona, 85029, United States|GSK Investigational Site, Jonesboro, Arkansas, 72401, United States|GSK Investigational Site, Concord, California, 94520, United States|GSK Investigational Site, Fresno, California, 93720, United States|GSK Investigational Site, Garden Grove, California, 92840, United States|GSK Investigational Site, La Jolla, California, 92037, United States|GSK Investigational Site, Long Beach, California, 90806, United States|GSK Investigational Site, Los Angeles, California, 90059, United States|GSK Investigational Site, Pasadena, California, 91105, United States|GSK Investigational Site, Sacramento, California, 95825, United States|GSK Investigational Site, Sacramento, California, 95841, United States|GSK Investigational Site, Walnut Creek, California, 94598, United States|GSK Investigational Site, West Hills, California, 91307, United States|GSK Investigational Site, Centennial, Colorado, 80112, United States|GSK Investigational Site, Denver, Colorado, 80209, United States|GSK Investigational Site, Longmont, Colorado, 80501, United States|GSK Investigational Site, Hamden, Connecticut, 06518, United States|GSK Investigational Site, Washington, District of Columbia, 20010, United States|GSK Investigational Site, Boynton Beach, Florida, 33437, United States|GSK Investigational Site, Deland, Florida, 32720, United States|GSK Investigational Site, Fort Meyers, Florida, 33907, United States|GSK Investigational Site, Hollywood, Florida, 33021, United States|GSK Investigational Site, Jacksonville, Florida, 32204, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Miami, Florida, 33156, United States|GSK Investigational Site, Ocala, Florida, 34471, United States|GSK Investigational Site, Pembroke Pines, Florida, 33024, United States|GSK Investigational Site, Sarasota, Florida, 34239, United States|GSK Investigational Site, West Palm Beach, Florida, 33401, United States|GSK Investigational Site, Atlanta, Georgia, 30328, United States|GSK Investigational Site, Atlanta, Georgia, 30342, United States|GSK Investigational Site, Augusta, Georgia, 30904, United States|GSK Investigational Site, Blue Ridge, Georgia, 30513, United States|GSK Investigational Site, Honolulu, Hawaii, 96813, United States|GSK Investigational Site, Honolulu, Hawaii, 96814, United States|GSK Investigational Site, Idaho Falls, Idaho, 83404, United States|GSK Investigational Site, Chicago, Illinois, 60607, United States|GSK Investigational Site, Chicago, Illinois, 60610, United States|GSK Investigational Site, Gurnee, Illinois, 60031, United States|GSK Investigational Site, Melrose Park, Illinois, 60160, United States|GSK Investigational Site, Orland Park, Illinois, 60462, United States|GSK Investigational Site, Springfield, Illinois, 62704, United States|GSK Investigational Site, Vernon Hills, Illinois, 60061, United States|GSK Investigational Site, Evansville, Indiana, 47714, United States|GSK Investigational Site, Indianapolis, Indiana, 46250, United States|GSK Investigational Site, South Bend, Indiana, 46601, United States|GSK Investigational Site, Wichita, Kansas, 67203, United States|GSK Investigational Site, Wichita, Kansas, 67208, United States|GSK Investigational Site, Madison, Kentucky, 42431, United States|GSK Investigational Site, Lake Charles, Louisiana, 70601, United States|GSK Investigational Site, Marrero, Louisiana, 70072, United States|GSK Investigational Site, Slidell, Louisiana, 70458, United States|GSK Investigational Site, Slidell, Louisiana, 70461, United States|GSK Investigational Site, Baltimore, Maryland, 21204, United States|GSK Investigational Site, Silver Spring, Maryland, 20910, United States|GSK Investigational Site, Haverhill, Massachusetts, 01831-2451, United States|GSK Investigational Site, Taunton, Massachusetts, 02780, United States|GSK Investigational Site, Cadillac, Michigan, 49601, United States|GSK Investigational Site, Troy, Michigan, 48098, United States|GSK Investigational Site, Picayune, Mississippi, 39466, United States|GSK Investigational Site, Chesterfield, Missouri, 63017, United States|GSK Investigational Site, Springfield, Missouri, 65807, United States|GSK Investigational Site, St. Louis, Missouri, 63108, United States|GSK Investigational Site, Butte, Montana, 59701, United States|GSK Investigational Site, Omaha, Nebraska, 68131, United States|GSK Investigational Site, Henderson, Nevada, 89014, United States|GSK Investigational Site, Las Vegas, Nevada, 89104, United States|GSK Investigational Site, Las Vegas, Nevada, 89119, United States|GSK Investigational Site, Pahrump, Nevada, 89048, United States|GSK Investigational Site, Hillsborough, New Jersey, 08844, United States|GSK Investigational Site, Kenilworth, New Jersey, 07033, United States|GSK Investigational Site, Martinsville, New Jersey, 08836, United States|GSK Investigational Site, Albuquerque, New Mexico, 87108, United States|GSK Investigational Site, Brooklyn, New York, 11216, United States|GSK Investigational Site, Buffalo, New York, 14209, United States|GSK Investigational Site, Cooperstown, New York, 13326, United States|GSK Investigational Site, Fulton, New York, 13009, United States|GSK Investigational Site, Johnson City, New York, 13790, United States|GSK Investigational Site, New Hyde Park, New York, 11042, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, New York, New York, 10024, United States|GSK Investigational Site, Staten Island, New York, 10301, United States|GSK Investigational Site, Cary, North Carolina, 27511, United States|GSK Investigational Site, Charlotte, North Carolina, 28209, United States|GSK Investigational Site, Charlotte, North Carolina, 28211, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Raleigh, North Carolina, 27612, United States|GSK Investigational Site, Winston-Salem, North Carolina, 27103, United States|GSK Investigational Site, Winston-Salem, North Carolina, 27157, United States|GSK Investigational Site, Bismarck, North Dakota, 58501, United States|GSK Investigational Site, Cincinnati, Ohio, 45219, United States|GSK Investigational Site, Cincinnati, Ohio, 45224, United States|GSK Investigational Site, Cincinnati, Ohio, 45241, United States|GSK Investigational Site, Cincinnati, Ohio, 45242, United States|GSK Investigational Site, Franklin, Ohio, 45005, United States|GSK Investigational Site, Kettering, Ohio, 45429, United States|GSK Investigational Site, Maumee, Ohio, 43537, United States|GSK Investigational Site, Sidney, Ohio, 45322, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73103, United States|GSK Investigational Site, Feasterville, Pennsylvania, 19053, United States|GSK Investigational Site, Lansdale, Pennsylvania, 19446, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19115, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19145, United States|GSK Investigational Site, Reading, Pennsylvania, 19611, United States|GSK Investigational Site, Scranton, Pennsylvania, 18510, United States|GSK Investigational Site, Cranston, Rhode Island, 02910, United States|GSK Investigational Site, Warick, Rhode Island, 02886, United States|GSK Investigational Site, Summerville, South Carolina, 29485, United States|GSK Investigational Site, Bartlett, Tennessee, 38134, United States|GSK Investigational Site, Bristol, Tennessee, 37620, United States|GSK Investigational Site, Cardova, Tennessee, 38018, United States|GSK Investigational Site, Arlington, Texas, 76017, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Dallas, Texas, 75246, United States|GSK Investigational Site, Galveston, Texas, 77555, United States|GSK Investigational Site, Houston, Texas, 77024, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, San Antonio, Texas, 78237, United States|GSK Investigational Site, San Antonio, Texas, 78238, United States|GSK Investigational Site, Chesapeake, Virginia, 23320, United States|GSK Investigational Site, Norfolk, Virginia, 23507, United States|GSK Investigational Site, Federal Way, Washington, 98003, United States|GSK Investigational Site, Tacoma, Washington, 98405, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53209-0996, United States|GSK Investigational Site
URL: https://clinicaltrials.gov/show/NCT00329225

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D116 Rosiglitazone small molecule DB00412 Details